Immunotherapy Before Sarcoma Surgery Improves Outcomes
Immunotherapy can improve outcomes in patients undergoing surgery for soft-tissue sarcoma Immunotherapy and radiation therapy prior to surgery led to 90% of patients having nearly all cancer cleared from their bodies Overall five-year survival rates were 90% and 82% for two common forms of soft-tissue sarcoma THURSDAY, Feb. 15, 2024Continue Reading